A cardinal feature of melanoma is its metastatic propensity. Paucity of insights into the genetic events that drive metastasis has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. Recent approaches that integrate human genomic and transcriptomic data provide unprecedented opportunities to discover oncogenic drivers in melanoma. However, the radically altered and complex ...